163 related articles for article (PubMed ID: 20528767)
1. Connecting the dots: molecular and epigenetic mechanisms in type 2 diabetes.
Goh KP; Sum CF
Curr Diabetes Rev; 2010 Jul; 6(4):255-65. PubMed ID: 20528767
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
Hossan T; Kundu S; Alam SS; Nagarajan S
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic flexibility in metabolic regulation: disease cause and prevention?
Kirchner H; Osler ME; Krook A; Zierath JR
Trends Cell Biol; 2013 May; 23(5):203-9. PubMed ID: 23277089
[TBL] [Abstract][Full Text] [Related]
4. The role of diet and exercise in the transgenerational epigenetic landscape of T2DM.
Barrès R; Zierath JR
Nat Rev Endocrinol; 2016 Aug; 12(8):441-51. PubMed ID: 27312865
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link.
Cheng Z; Almeida FA
Cell Cycle; 2014; 13(6):890-7. PubMed ID: 24552811
[TBL] [Abstract][Full Text] [Related]
6. Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
Naidoo V; Naidoo M; Ghai M
Scand J Immunol; 2018 Dec; 88(6):e12723. PubMed ID: 30589455
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of histone deacetylase 3 (
Sathishkumar C; Prabu P; Balakumar M; Lenin R; Prabhu D; Anjana RM; Mohan V; Balasubramanyam M
Clin Epigenetics; 2016; 8():125. PubMed ID: 27904654
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus.
Alam F; Islam MA; Gan SH; Mohamed M; Sasongko TH
Curr Pharm Des; 2016; 22(28):4398-419. PubMed ID: 27229720
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in genetic and epigenetic research on type 2 diabetes.
Kwak SH; Park KS
Exp Mol Med; 2016 Mar; 48(3):e220. PubMed ID: 26964836
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
11. The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects.
Khatami F; Mohajeri-Tehrani MR; Tavangar SM
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):719-731. PubMed ID: 31122183
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Modifications as Outcomes of Exercise Interventions Related to Specific Metabolic Alterations: A Systematic Review.
Barrón-Cabrera E; Ramos-Lopez O; González-Becerra K; Riezu-Boj JI; Milagro FI; Martínez-López E; Martínez JA
Lifestyle Genom; 2019; 12(1-6):25-44. PubMed ID: 31546245
[TBL] [Abstract][Full Text] [Related]
13. Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
Coco C; Sgarra L; Potenza MA; Nacci C; Pasculli B; Barbano R; Parrella P; Montagnani M
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212911
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
[TBL] [Abstract][Full Text] [Related]
15. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?
Patti ME
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):383-90. PubMed ID: 15192439
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.
Sommese L; Zullo A; Mancini FP; Fabbricini R; Soricelli A; Napoli C
Epigenetics; 2017 Jun; 12(6):401-415. PubMed ID: 28059593
[TBL] [Abstract][Full Text] [Related]
17. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.
Goh KP; Lee HY; Lau DP; Supaat W; Chan YH; Koh AF
Int J Sport Nutr Exerc Metab; 2014 Feb; 24(1):2-13. PubMed ID: 23918588
[TBL] [Abstract][Full Text] [Related]
18. Understanding type 2 diabetes: from genetics to epigenetics.
Raciti GA; Longo M; Parrillo L; Ciccarelli M; Mirra P; Ungaro P; Formisano P; Miele C; Béguinot F
Acta Diabetol; 2015 Oct; 52(5):821-7. PubMed ID: 25841587
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-18a and miR-34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance.
Wang SS; Li YQ; Liang YZ; Dong J; He Y; Zhang L; Yan YX
J Cell Mol Med; 2017 Dec; 21(12):3372-3380. PubMed ID: 28661068
[TBL] [Abstract][Full Text] [Related]
20. Recent developments on the role of epigenetics in obesity and metabolic disease.
van Dijk SJ; Tellam RL; Morrison JL; Muhlhausler BS; Molloy PL
Clin Epigenetics; 2015; 7():66. PubMed ID: 27408648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
